8-47890319-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006904.7(PRKDC):​c.4009G>A​(p.Val1337Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,613,286 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1337A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00097 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 3 hom. )

Consequence

PRKDC
NM_006904.7 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.657

Publications

4 publications found
Variant links:
Genes affected
PRKDC (HGNC:9413): (protein kinase, DNA-activated, catalytic subunit) This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
PRKDC Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to DNA-PKcs deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011308938).
BP6
Variant 8-47890319-C-T is Benign according to our data. Variant chr8-47890319-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 542005.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006904.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKDC
NM_006904.7
MANE Select
c.4009G>Ap.Val1337Ile
missense
Exon 32 of 86NP_008835.5
PRKDC
NM_001081640.2
c.4009G>Ap.Val1337Ile
missense
Exon 32 of 85NP_001075109.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKDC
ENST00000314191.7
TSL:1 MANE Select
c.4009G>Ap.Val1337Ile
missense
Exon 32 of 86ENSP00000313420.3
PRKDC
ENST00000338368.7
TSL:1
c.4009G>Ap.Val1337Ile
missense
Exon 32 of 85ENSP00000345182.4

Frequencies

GnomAD3 genomes
AF:
0.000966
AC:
147
AN:
152098
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00148
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00104
AC:
258
AN:
248958
AF XY:
0.00104
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000929
Gnomad NFE exome
AF:
0.00174
Gnomad OTH exome
AF:
0.00198
GnomAD4 exome
AF:
0.00169
AC:
2473
AN:
1461070
Hom.:
3
Cov.:
30
AF XY:
0.00157
AC XY:
1142
AN XY:
726776
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33470
American (AMR)
AF:
0.00130
AC:
58
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86144
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53394
Middle Eastern (MID)
AF:
0.000371
AC:
2
AN:
5396
European-Non Finnish (NFE)
AF:
0.00207
AC:
2307
AN:
1111816
Other (OTH)
AF:
0.00146
AC:
88
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
127
255
382
510
637
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000966
AC:
147
AN:
152216
Hom.:
0
Cov.:
32
AF XY:
0.000968
AC XY:
72
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41546
American (AMR)
AF:
0.00235
AC:
36
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00149
AC:
101
AN:
68010
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000739
Hom.:
0
Bravo
AF:
0.00117
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000256
AC:
1
ESP6500EA
AF:
0.00181
AC:
15
ExAC
AF:
0.000893
AC:
108
EpiCase
AF:
0.00207
EpiControl
AF:
0.00184

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 16, 2017
Blueprint Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Severe combined immunodeficiency due to DNA-PKcs deficiency Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.15
DANN
Benign
0.71
DEOGEN2
Benign
0.073
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.75
T
M_CAP
Benign
0.0033
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.17
N
PhyloP100
0.66
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.33
N
REVEL
Benign
0.14
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0020
B
Vest4
0.17
MVP
0.38
MPC
0.14
ClinPred
0.016
T
GERP RS
-4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.026
gMVP
0.12
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56080897; hg19: chr8-48802880; API